Natixis Inogen Inc Transaction History

Natixis

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$32.85 - $53.77 $657,000 - $1.08 Million	-20,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$45.95 - $76.15 $919,000 - $1.52 Million	20,000 New	20,000 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$112.83 - $239.74 $141,037 - $299,675	-1,250 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $236,375 - $353,650	1,250 New	1,250 $305,000
Q4 2017 Feb 14, 2018	SELL	$93.4 - $128.74 $234,247 - $322,879	-2,508 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$91.08 - $104.49 $228,428 - $262,060	2,508	2,508 $239,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $218M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.